Privia Health Q3'26 Conference Call - PRIVIA HEALTH GROUP INC

Financial Performance:

• Year-to-date practice collections grew 12% to $2.91 billion; adjusted EBITDA rose 21.9% to $114.7 million, representing a 28.8% margin on care.
• Implemented providers increased 12.2% YoY to 5,893; value-based attributed lives grew 19.2% to over 6.3 million.
• Ended Q3 with $446.3 million in cash, zero debt, and a full-year free cash flow conversion target of 70% of adjusted EBITDA.
• Strong operating leverage demonstrated as EBITDA margins expanded from ~16% pre-IPO to near 29% under current guidance.

Guidance and Future Outlook:

• Raised 2026 outlook across all key metrics above the initial high-end guidance due to strong execution.
• Full-year implemented providers now expected to reach the high end of 6,000 (11.5% growth over 2025).
• Adjusted EBITDA growth guidance raised to a 23.9% midpoint for 2026.
• Full-year practice collections and care margins expected to grow 13.1% and 16.3% respectively.
• Management projects a full-year cash balance of at least $520 million.

Business Segments and Product Lines:

• Value-Based Care: Serves 1.67 million attributed lives across 130+ programs; Medicare Advantage lives grew 11.8%, while CMS Medicare lives surged 59%.
• M&A Activity: Acquired American Choice Healthcare MSSP ACO (subsidiary of Kano Health) for ~$36M in cash, adding ~36,000 attributed lives and entering three new states.
• Strategic Exit: Ending partnership with Surgery Partners in Montana (Jan 2027) affecting 69 providers and ~$23M in annual collections; deemed immaterial to 2027 EBITDA.
• Ancillary Expansion: Expanding into adjacent lines including labs and ASCs to lower costs and improve outcomes.

Market and Competitive Landscape:

• Operating footprint covers 25 states and DC with over 1,400 care center locations; addresses a TAM of >1 million providers.
• Commercial attribution reached 966,000 lives, demonstrating diversification beyond government programs.
• Industry consolidation trends are creating opportunities for accretive acquisitions of assets trading at lower multiples than Privia.
• Medicare Advantage market expected to stabilize post-regulatory changes (V28, Star scores), driving demand for managed risk partners.

Risks and Challenges:

• Regulatory Uncertainty: Monitoring final CMS MSSP 2025 results and Physician Fee Schedule impacts, though current guidance incorporates these nuances.
• Market Volatility: Potential disruption from "One Big Beautiful Act" attribution shifts, uninsured population growth, and varying state-level payer dynamics.
• Integration Risks: Managing the integration of acquired ACOs into existing operations while maintaining performance metrics.
• Partnership Dependencies: Exiting the Montana partnership highlights the risk of alignment issues with external partners (e.g., Surgery Partners sale).

Management Commentary and Tone:

• Tone was highly confident, emphasizing "durable growth algorithms," "operational excellence," and the "compounding" nature of the business model.
• CEO highlighted five strategic growth pillars: organic practice growth, market expansion, value-based attribution, capital deployment, and adjacent market expansion.
• Management reiterated the shift from partnership reliance to direct ownership due to increased balance sheet strength and strategic flexibility.
• Expressed optimism on the long-term viability of community-based care and the ability to capture value as payers seek cost control.

Analyst Questions and Answers:

• M&A Strategy: Clarified that the Kano/American Choice deal was attractive due to bankruptcy-driven pricing; future deals will target high-quality assets at favorable multiples.
• Capex & Capital Allocation: With ~$500M cash and $300-400M debt capacity, the company has $800-900M acquisition firepower; returns to shareholders (buybacks/dividends) are being evaluated but M&A remains the primary capital use case.
• Revenue vs. EBITDA: Revenue beats are partly driven by the Florida medical group acquisition moving from ASC-only to full GAAP revenue recognition.
• Monetization of ASCs: Exited a specific surgery partner in Montana for strategic fit reasons, not a strategic shift away from ASCs; remains "forward-leaning" on owning ancillary assets.
• Cost Trends: Ambulatory utilization and costs remain stable and positive; inpatient cost trends are variable but well-managed within the value-based book.
• Medicare Outlook: Bullish on MSSP and LEED programs due to demographic aging and CMS program evolution; MA contract renewals largely in place.

Other Key Points:

• The company operates a unique "single TIN" model for most practices, differentiating it from competitors.
• The acquisition of American Choice expands the Privia Care Partners VBC footprint to 13 states.
• Management noted that while growth is not a straight line, the five-year trajectory of adding 600+ providers annually validates the sales engine.
• Effective tax rate is stable at approximately 27%, supporting strong FCF conversion expectations.